FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116595005: Triamcinolone diacetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177240014 Triamcinolone diacetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
680008016 Triamcinolone diacetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
847321000172112 diacétate de triamcinolone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Triamcinolone diacetate Is a Triamcinolone false Inferred relationship Some
Triamcinolone diacetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Triamcinolone true Inferred relationship Some
Triamcinolone diacetate Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Some
Triamcinolone diacetate Is a Pregnane (substance) true Inferred relationship Some
Triamcinolone diacetate Is a Fluorinated corticosteroid true Inferred relationship Some
Triamcinolone diacetate Is a Glucocorticoid (substance) true Inferred relationship Some
Triamcinolone diacetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Triamcinolone diacetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Triamcinolone diacetate Inferred relationship Some
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Triamcinolone diacetate Inferred relationship Some
Triamcinolone diacetate 25mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Triamcinolone diacetate Inferred relationship Some
Triamcinolone diacetate 40mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Triamcinolone diacetate Inferred relationship Some
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Triamcinolone diacetate Inferred relationship Some 1
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Triamcinolone diacetate Inferred relationship Some 1
Triamcinolone diacetate 25 mg/mL suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Triamcinolone diacetate Inferred relationship Some 1
Triamcinolone diacetate 25 mg/mL suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Triamcinolone diacetate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start